IDIVAL has just published the progress of its annual report summarizing the main milestones and data of activity developed, both in terms of scientific production and economic results. Throughout its 22 pages prologued by the President of the IDIVAL Board of Trustees and Counselor of Health of the Government of Cantabria, Maria Luisa Real, the […]
Institute of Health Carlos III (ISCIII) has granted the research lines of Transplantation and Autoimmunity group at the Health Research and Development Strategy 2016. This group is part of the Health Research Institute Marques de Valdecilla (IDIVAL) and is leaded by the researcher Marcos López Hoyos, Head of the Immunology Department at the HUMV (Marques […]
Group of Infection and Immunity of the Digestive System of IDIVAL led by from Marqués de Valdecilla University Hospital and the University of Cantabria has just joined as a Group linked to CIBER. This Group focuses on the study of viral hepatitis where it has already become a national reference, and in liver fat deposition […]
Animal models of schizophrenia constitute at this moment fundamental experimentation tools to further explore on the etiological basis of this pathology, leading to the discovery of new biological targets and innovative therapeutic strategies for its treatment. Our research group Prof. Dr. Crespo-Facorro, Dr. Juan F. Lopez-Giménez (CSIC) and the research team of Prof. Dr. Gonzalez-Maeso […]
Institute of Health Carlos III granted the project “Targeted exonic next generation sequencing for the molecular diagnosis and cell free tumor DNA analysis as screening method for patients with DLBCL” in the call for grants Health Research and Development Strategy 2016 File Nº: PI16/01397 with the amount of 98.615€. The research project is led by Dr. Santiago […]
This week the journal Science has published in the editorial a paper in which have collaborated researchers from the University Hospital Marqués de Valdecilla and the University of Cantabria. The work has also been referenced in BioCentury. This reference marks a real milestone and points out the enormous interest and projection of the discoveries that […]
Our ability to control infectious diseases is continuously being eroded by antimicrobial resistance, a current major health problem worldwide. A large proportion of the research activities in our group is related to the study of physiological and biochemical aspects of the mechanisms of resistance to antimicrobial agents in bacteria. We consider clinical relevant Enterobacteria and […]
Nowadays, osteoporosis due to the progressive aging of the population, is becoming one of the most frequent diseases of our time. Decreased quality of life (for example, inability to walk again after a hip fracture) and the increase in mortality it determines, justifies intensive research efforts. IDIVAL Bone and Lipid Metabolism Group, researchers at the […]
Researchers belonging to the Valdecilla Hospital and the University of Cantabria, of the IDIVAL Group Cytokines and growth factors in pathological tissue plasticity phenomena have collaborated in a study published last Monday in the prestigious journal Nature Medicine in which it is shown that the pharmacological inhibition of The NOS2 protein not only prevents pathological dilatation […]
T lymphocytes are blood cells whose mission is to destroy the malignant cells that affect our organism. They fight against diseased cells that sometimes originate in organs or those that have been infected by viruses. However, when they undergo certain genetic alterations they can cause tumors such as peripheral T-cell lymphomas, which have a very […]
